Nemus Bioscience (NMUS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | NMUS | AMGN | GILD | CELG | ILMN |
| Company | Nemus Bioscience | Amgen Inc | Gilead Sciences Inc | Celgene Corp | Illumina Inc |
| Price Information | |||||
| Exchange | OTC US | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 0.7185 | 333.93 | 83.37 | 108.01 | 130.19 |
| High | 0.7189 | 339.00 | 84.52 | 108.59 | 134.94 |
| Low | 0.6000 | 331.00 | 82.76 | 107.27 | 129.69 |
| Last | 0.6500 | 334.41 | 84.09 | 108.24 | 132.77 |
| Change | -0.0684 | +1.61 | +1.04 | +0.11 | +2.56 |
| % Change | -9.52% | +0.48% | +1.25% | +0.10% | +1.97% |
| Volume | 1,004,500 | 775,528 | 6,138,788 | 191,230,496 | 1,327,291 |
| 20-Day Average Volume | 494,515 | 1,703,773 | 6,258,449 | 16,188,930 | 1,325,875 |
| Previous Close | 0.7184 | 332.80 | 83.05 | 108.13 | 130.21 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | No | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.5046 | 329.42 | 79.66 | 108.17 | 129.24 |
| 20-Day Raw Stochastic | 72.67% | 87.95% | 95.64% | 63.25% | 88.78% |
| 20-Day Relative Strength | 63.72% | 57.88% | 72.86% | 64.69% | 59.56% |
| Weighted Alpha | +34.72 | +27.34 | +19.31 | +46.30 | +7.55 |
| Today's Opinion | 100% Buy | 96% Buy | 88% Buy | 100% Buy | 72% Buy |
| Previous Opinion | 100% Buy | 88% Buy | 88% Buy | 100% Buy | 64% Buy |
| Last Month's Opinion | 88% Buy | 72% Buy | 40% Buy | 100% Buy | 24% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +40.54% since 03/15/19 | +1.95% since 09/11/24 | +4.34% since 09/11/24 | -1.97% since 11/13/19 | +6.99% since 09/11/24 |
| Low | 0.4700 on 03/18/19 | 326.41 on 09/12/24 | 81.57 on 09/13/24 | 107.27 on 11/20/19 | 120.51 on 09/12/24 |
| High | 0.7440 on 03/21/19 | 338.80 on 09/18/24 | 84.89 on 09/12/24 | 110.53 on 11/14/19 | 134.94 on 09/18/24 |
| 1-Month | |||||
| %Chg | +31.31% since 02/22/19 | +4.66% since 08/16/24 | +14.46% since 08/16/24 | +5.14% since 10/18/19 | +2.49% since 08/16/24 |
| Low | 0.4000 on 03/11/19 | 319.00 on 09/06/24 | 73.27 on 08/19/24 | 102.40 on 10/21/19 | 120.51 on 09/12/24 |
| High | 0.7440 on 03/21/19 | 338.80 on 09/18/24 | 84.89 on 09/12/24 | 110.70 on 11/13/19 | 137.18 on 08/20/24 |
| 3-Month | |||||
| %Chg | +62.54% since 12/21/18 | +9.94% since 06/18/24 | +33.73% since 06/18/24 | +13.63% since 08/20/19 | +23.55% since 06/18/24 |
| Low | 0.3000 on 01/31/19 | 303.55 on 06/20/24 | 64.86 on 06/20/24 | 93.41 on 08/23/19 | 103.52 on 06/28/24 |
| High | 0.7440 on 03/21/19 | 346.85 on 07/25/24 | 84.89 on 09/12/24 | 110.70 on 11/13/19 | 137.18 on 08/20/24 |
| 6-Month | |||||
| %Chg | +120.34% since 09/21/18 | +24.18% since 03/18/24 | +15.27% since 03/18/24 | +14.14% since 05/20/19 | +2.63% since 03/18/24 |
| Low | 0.0500 on 10/31/18 | 260.68 on 04/19/24 | 62.07 on 05/31/24 | 89.08 on 07/23/19 | 100.08 on 05/30/24 |
| High | 0.7440 on 03/21/19 | 346.85 on 07/25/24 | 84.89 on 09/12/24 | 110.70 on 11/13/19 | 144.19 on 03/21/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 87,040 | 178,525,568 | 103,468,096 | 77,035,920 | 20,742,456 |
| Shares Outstanding, K | 133,908 | 536,435 | 1,245,853 | 711,714 | 159,300 |
| Annual Sales | 0 | 28,190,000,000 | 27,116,000,000 | 15,281,000,000 | 4,504,000,000 |
| Annual Net Income | -19,190,000 | 6,717,000,000 | 5,665,000,000 | 4,046,000,000 | -1,161,000,000 |
| Last Quarter Sales | 0 | 8,388,000,000 | 6,954,000,000 | 4,520,000,000 | 1,112,000,000 |
| Last Quarter Net Income | -6,220,000 | 746,000,000 | 1,614,000,000 | 1,691,000,000 | -1,988,000,000 |
| 60-Month Beta | -0.04 | 0.61 | 0.18 | 1.41 | 1.15 |
| Per-Share Information | |||||
| Most Recent Earnings | N/A | 4.97 on 08/06/24 | 2.01 on 08/08/24 | 2.99 on 10/31/19 | 0.36 on 08/06/24 |
| Latest Earnings Date | 10/05/18 | 10/29/24 | 11/05/24 | 10/31/19 | 08/06/24 |
| Most Recent Dividend | N/A | 2.250 on 08/16/24 | 0.770 on 09/13/24 | N/A | N/A |
| Next Ex-Dividends Date | N/A | 08/16/24 | 09/13/24 | N/A | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 18.02 | 17.69 | 10.99 | 140.78 |